
OraSure Technologies (NASDAQ:OSUR) specializes in the development, manufacture, and distribution of diagnostic tests and sample collection devices. The company focuses on providing products for the detection of infectious diseases and the collection, stabilization, and transport of biological samples. OraSure aims to improve health outcomes by providing quick, accurate, and accessible diagnostic solutions for conditions such as HIV, hepatitis C, and Ebola, as well as for genomics and microbiome applications. Their product range also supports the growing needs of the molecular diagnostics field, including solutions for COVID-19 testing. With a commitment to innovation, OraSure continually strives to expand its product offerings and global reach, aiming to meet the evolving health diagnostics and sample collection needs of both the healthcare sector and consumers directly.